Busch Matthew C. sold AMGN
March 16, 2026 · Form 4 insider transaction
Busch Matthew C. sold 327 shares of Amgen Inc. at $366.21 per share, a transaction worth $119.8K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
327
Price
$366.21
Total value
$119.8K
InsiderBusch Matthew C.
Role—
CompanyAmgen Inc. (AMGN)
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateMarch 16, 2026
Filing dateMarch 18, 2026
Shares owned after4,048
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These shares include 68 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.